Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Assets (2021 - 2025)

LifeStance Health (LFST) has disclosed Assets for 5 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • Quarterly Assets rose 4.04% to $2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 4.04% year-over-year, with the annual reading at $2.2 billion for FY2025, 4.04% up from the prior year.
  • Assets for Q4 2025 was $2.2 billion at LifeStance Health, up from $2.1 billion in the prior quarter.
  • The five-year high for Assets was $2.2 billion in Q4 2025, with the low at $1.9 billion in Q2 2021.
  • Average Assets over 5 years is $2.1 billion, with a median of $2.1 billion recorded in 2023.
  • The sharpest move saw Assets increased 12.8% in 2022, then fell 3.09% in 2024.
  • Over 5 years, Assets stood at $1.9 billion in 2021, then rose by 12.8% to $2.2 billion in 2022, then fell by 2.94% to $2.1 billion in 2023, then grew by 0.39% to $2.1 billion in 2024, then grew by 4.04% to $2.2 billion in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $2.2 billion, $2.1 billion, and $2.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.